Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following Nephrectomy

Renal cell carcinoma (RCC) is the fourteenth most common cancer worldwide. In about 55% of cases, it is diagnosed at a localised and/or locally advanced stage and therefore amenable to a curative approach. Although nephrectomy still represents the cornerstone of non-metastatic RCC (nmRCC) treatment,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bottiglieri, Achille, Sepe, Pierangela, Stellato, Marco, Pircher, Chiara, Fotia, Giuseppe, Leone, Alberto Giovanni, Guadalupi, Valentina, Claps, Melanie, Giannatempo, Patrizia, Verzoni, Elena, Procopio, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584769/
https://www.ncbi.nlm.nih.gov/pubmed/36275783
http://dx.doi.org/10.2147/CMAR.S360441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584769/
https://www.ncbi.nlm.nih.gov/pubmed/36275783
http://dx.doi.org/10.2147/CMAR.S360441

Ejemplares similares